Summary
51 / 100 · Bulios Score
What speaks for it
- Revenue grew by 14% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share fell by 36% a year over the last 3 years.
- It missed profit estimates 6 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 8.2% a year over 5 years. Over the last 3 years it grew by 14% a year. Earnings per share fell by 36% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $37.1M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 35.09%
You receive $0.40 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 4
- Hold 9
- Sell 2
Today's price within the analysts' price targets
The average target of $2.9 is 100% above today's price. 27% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.